Cargando…
Challenges in Treating Charcot-Marie-Tooth Disease and Related Neuropathies: Current Management and Future Perspectives
There is still no effective drug treatment available for Charcot-Marie-Tooth neuropathies (CMT). Current management relies on rehabilitation therapy, surgery for skeletal deformities, and symptomatic treatment of pain; fatigue and cramps are frequent complaints that are difficult to treat. The chall...
Autores principales: | Pisciotta, Chiara, Saveri, Paola, Pareyson, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615778/ https://www.ncbi.nlm.nih.gov/pubmed/34827446 http://dx.doi.org/10.3390/brainsci11111447 |
Ejemplares similares
-
Charcot–Marie–Tooth disease type 2F associated with biallelic HSPB1 mutations
por: Abati, Elena, et al.
Publicado: (2021) -
DNAJB2‐related Charcot‐Marie‐Tooth disease type 2: Pathomechanism insights and phenotypic spectrum widening
por: Saveri, Paola, et al.
Publicado: (2022) -
Frequency, entity and determinants of fatigue in Charcot–Marie–Tooth disease
por: Bellofatto, Marta, et al.
Publicado: (2022) -
Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease
por: Bellofatto, Marta, et al.
Publicado: (2023) -
Correction to: Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease
por: Bellofatto, Marta, et al.
Publicado: (2023)